Seeking Alpha

NuVasive, Inc. (NUVA)

  • Quantified Alpha | Send Message 3 May

    12 straight beats on revenue expectations, and a 21% beat on EPS last quarter, $NUVA has earnings momentum
      • Stephen Simpson, CFA | Send Message 13 Mar

        Can NuVasive 2.0 Take The Shares To New Highs? $NUVA
          • LaboMedic | Send Message 13 Jan

            $NUVA Brean Capital Maintains Buy NuVasive Following Preliminary 4Q14 Results
              • Andy Batts | Send Message 7 Nov 2014

                Update: NuVasive Q3 2014 Earnings $NUVA
                  • Christopher F. Davis | Send Message 30 Sep 2014

           What these changes mean for these stocks $ATHL $CENX $CSC $LMT $TM $K $MLNK $NI $NUVA $PTEN $RTN $SGEN
                      • Andy Batts | Send Message 12 Aug 2014

                        Update: Judge Cancels NuVasive's Trademark On The NeuroVision Name $NUVA
                          • Stephen Simpson, CFA | Send Message 31 Jul 2014

                            NuVasive Running On Renewed MIS Vigor $NUVA
                              • freefdawatchlist | Send Message 9 Apr 2014

                       Premarket Trading Ideas for April 10th: $UVXY, $TVIX, $XIV, $DUST, $NUGT, $NQ, $JPM $WFC $RAD $ANR $WLT $NUVA
                                  • Andy Batts | Send Message 21 Mar 2014

                                    NuVasive's Innovative Product Launches To Drive Growth, Stock Has Significant Upside $NUVA
                                      • Jeff Pierce | Send Message 17 Jan 2014

                                        I would be a seller into today`s strength if I still owned $NUVA. I sold way to early on this one.
                                          Visit Seeking Alpha's
                                          NUVA vs. ETF Alternatives
                                          Company Description
                                          NuVasive Inc is a medical device company. The Company develops minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its currently-marketed product portfolio is focused on applications for spine fusion surgery.